Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Toxoplasma gondii | cathepsin CPC1 | 0.4274 | 1 | 1 |
Toxoplasma gondii | preprocathepsin c precursor, putative | 0.4274 | 1 | 1 |
Schistosoma mansoni | dipeptidyl-peptidase I (C01 family) | 0.4274 | 1 | 1 |
Plasmodium vivax | dipeptidyl aminopeptidase 2, putative | 0.4274 | 1 | 1 |
Plasmodium vivax | dipeptidyl aminopeptidase 1, putative | 0.4274 | 1 | 1 |
Plasmodium falciparum | dipeptidyl aminopeptidase 1 | 0.4274 | 1 | 1 |
Trichomonas vaginalis | Clan CA, family C1, cathepsin B-like cysteine peptidase | 0.2652 | 0.5741 | 0.5 |
Echinococcus granulosus | tm gpcr rhodopsin | 0.1011 | 0.1432 | 1 |
Echinococcus multilocularis | tm gpcr rhodopsin gpcr rhodopsin superfamily | 0.1011 | 0.1432 | 1 |
Plasmodium falciparum | dipeptidyl aminopeptidase 2 | 0.4274 | 1 | 1 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.